Znn3bq.jpeg
²é¿´: 5950  |  »Ø¸´: 12

ÏÂÓêÌì??

гæ (СÓÐÃûÆø)

[½»Á÷] ssci2ÇøÍ¶¸åÏÖÊÕµ½´óÐÞ£¬Çë¸÷λÓÑÓѰïæ¿´¿´Ñ½£¡ ÒÑÓÐ7È˲ÎÓë

Á½Ô³õͶµÄssci 6.2¸ø»Ø¸´ÁË 7ÔÂ14ÈÕǰÉÏ´«Îļþ¡£
µÚÒ»´ÎͶ¸å°¡£¬»¹ÊÇ×Ô¼ºÒ»¸öÔÚ×öѧÊõ£¬Ã»ÓÐÍŶӣ¬ËùÒÔ¹òÇóÓÑÓÑÃǰïÎÒ¿´¿´¸ø¸øÒâ¼û£¡£¡
£¨µÚÒ»´Îд¸å²»Ò»¶¨Í¼Æ¬¿ÉÒÔ¼Ó½øÀ´£¬ËùÒÔ°ÑÉó¸åÒâ¼ûµÈÎÄ×Ö°æ±¾·¢³öÀ´ÁË


Referee: 1

Comments to the Author
This manuscript studies the impact of two forms of government innovation assistance programs - innovation subsidies and tax refunds - on the R&D production of Chinese pharmaceutical companies. This is a very interesting research topic for us. The study tests a number of hypotheses and draws conclusions through quantitative analysis. However, I would like to see more concrete raw data on the quantitative analysis. Otherwise, I do not find it very convincing. I would also like to see a specific discussion of the differences from previous studies. I believe the paper will be even better if you do so.
More specifically, I am worried about the following points.


(1) The authors present many hypotheses which are H1a, H1b, H2a, H2b, H3a, H3b, H4a, and H4b and analyze them quantitatively. The variable definitions and descriptive statistics are listed in Table1 and Table2 and the regression results for each model are shown the Table 3, Table 4, Table 5, Table 6, and Table 7. These results are then used to test the hypotheses and draw conclusions. However, the actual contents of Table1 and Table2 are black boxes, and there is no way to verify them. Also, there seems to be no explanation of the model from 1 to 4.

(2) Also, regarding the INPI that means the total number of patents in Table 1, the results are not compared and discussed with those of Cappelen et al. (2012) and Moretti and Wilson (2014), which are cited as previous studies. There is no crucial discussion of how the current results in China differ from the results in those other countries and also the reason why in this manuscript.

I cannot make an accurate judgment because I lack the materials to make a solid decision.


Referee: 2

Comments to the Author
Dear Author(s),
Overall paper is very well written and meets the required standards. However, a few suggestions are put forward to make its worth reading.
1. Abstract: A paragraph on methodology can make it a comprehensive abstract.
2. Literature review should be updated with a few recent papers i.e. 2020-21
3. Methodology: Page 09, line 36, 'Special Treatment (ST*) need to be defined in comprehensive way for the readers.
4. Moderator: page 11, The author(s) should clearly explain the time line and technique used to collect the primary data.
5. VIF threshold reference is missing. Author(s) may consider to provide even conservative reference due to given results.
6. It was observed that Author(s) have used different styles of result reporting, it may be uniformed with providing beta value and p-values i.e. page 17, line 55-60
7. Discussion and Conclusion: Author(s) must add some references in (Point-2) to strengthen the discussion part as provided in the same section i.e. (1 and 3)
8. Page 30, line 47, I guess it must be competitiveness rather than 'competitive'
9. In my opinion, a separate section on limitations and future research directions can make study worth reading.




EditorµÄÖ÷ÒªÇãÏòÊÇ£ºYou will see that although the referees find some merit in the paper it is required that substantial revisions be done before we can consider it further.  Nevertheless, we do hope that you will be able to undertake the additional work on the paper and look forward to receiving a revised manuscript in due course.


ºÜ»Ì¿Ö£¡Ö÷±àµÄÒâ˼ÊÇÄܲ»ÄÜÖÐÄØ£¿»¹ÓÐReferee: 1ÔÚ˵µÄblack boxes ÊÇɶÒâ˼£¿ÊÇÔÚ˵ÎÒµÄÊý¾ÝÂÛÖ¤²»ÇåÎúô£¿»¹ÊÇÔÚ¾õµÃÎÒÊý¾Ý²»ÕæÊµÄØ£¿£¿
ÇòÇòÁË °ïÎÒ¸øµãÒâ¼û°É£¡£¡£¡£¡
±ÈÐÄ
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
»ØÌûÖ§³Ö ( ÏÔʾ֧³Ö¶È×î¸ßµÄǰ 50 Ãû )

SenX

½ð³æ (ÕýʽдÊÖ)

´óÐÞ¾ÍÓÐÏ£Íû black box¸Ð¾õÔÚ˵²»Ì«Á˽âÄãµÄ½áÂÛÊÇÈçºÎµÃ³öµÄ£¬Ò²ÄÑÒÔÑéÖ¤

·¢×ÔСľ³æAndroid¿Í»§¶Ë
3Â¥2022-06-10 08:42:33
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

holypower

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
±à¼­Êdzֻý¼«Ì¬¶ÈµÄ£¬µ«ÄãÐèÒªÈÃÉó¸åÈË1ÐÅ·þÄãµÄÊý¾Ý£¬Ä¿Ç°À´¿´Ëû¾õµÃºÜÄÑÅжÏÄãµÄÊý¾ÝÕæÊµÐÔ£¡×î¼òµ¥µÄ·½·¨¾ÍÊǸ½ÉÏԭʼÊý¾Ý

·¢×ÔСľ³æIOS¿Í»§¶Ë
5Â¥2022-06-10 09:41:22
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏÂÓêÌì??

гæ (СÓÐÃûÆø)

ÒýÓûØÌû:
5Â¥: Originally posted by holypower at 2022-06-10 09:41:22
±à¼­Êdzֻý¼«Ì¬¶ÈµÄ£¬µ«ÄãÐèÒªÈÃÉó¸åÈË1ÐÅ·þÄãµÄÊý¾Ý£¬Ä¿Ç°À´¿´Ëû¾õµÃºÜÄÑÅжÏÄãµÄÊý¾ÝÕæÊµÐÔ£¡×î¼òµ¥µÄ·½·¨¾ÍÊǸ½ÉÏԭʼÊý¾Ý

²»ÊǺÜÏ븽ÉÏԭʼÊý¾Ý£¬Óв¿·ÖÊÇÊÖ¶¯ÊÕ¼¯µÄ»¨ÁËÀϱÇ×Ó¾¢¡£¶øÇÒÎÒ²»ÊǺÜÀí½â£¬Èç¹ûԭʼÊý¾Ý·¢¹ýÈ¥»á¹«¿ªÃ´£¿£¨ÆäʵÎÒµÄ̬¶È»¹ÊÇÏ£Íû²»Ï£ÍûËѼ¯ÕûÀíµÄԭʼÊý¾Ý±»¹«¿ª£¬ºóÐø»¹×¼±¸¼ÌÐøÓÃд·¢ÎÄÕÂ
6Â¥2022-06-10 09:58:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÆÕͨ»ØÌû

1018415371

гæ (ÕýʽдÊÖ)

2Â¥2022-06-10 08:36:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏÂÓêÌì??

гæ (СÓÐÃûÆø)

ÒýÓûØÌû:
3Â¥: Originally posted by SenX at 2022-06-10 08:42:33
´óÐÞ¾ÍÓÐÏ£Íû black box¸Ð¾õÔÚ˵²»Ì«Á˽âÄãµÄ½áÂÛÊÇÈçºÎµÃ³öµÄ£¬Ò²ÄÑÒÔÑéÖ¤

¸Ð¼¤£¡ÎÒ¼ÓÓÍŬÁ¦£¡
4Â¥2022-06-10 08:50:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

EmeraldTSS

½ûÑÔ (³õÈëÎÄ̳)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
±¾ÌûÄÚÈݱ»ÆÁ±Î

7Â¥2022-06-10 10:41:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

kmght

Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)

AP

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ö÷±àÄǸöÊÇÌ×»°£¬ÓÐɶÇãÏòÐÔ¡­¾ÍËãÈÃÄãºÃºÃ¸Ä

·¢×ÔСľ³æIOS¿Í»§¶Ë
Practice-makes-perfect
8Â¥2022-06-10 16:28:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÏÂÓêÌì??

гæ (СÓÐÃûÆø)

ÒýÓûØÌû:
7Â¥: Originally posted by EmeraldTSS at 2022-06-10 10:41:44
´Ó±à¼­Éó¸åºÍ±à¼­Òâ¼ûÀ´¿´£¬ÂÛÎĺÜÓÐÏ£Íû£º
1. his is a very interesting research topic for us. ˵Ã÷Ñ¡ÌâºÜ¶Ô¿Ú£¬ÊÇÆÚ¿¯·Ç³£¸ÐÐËȤµÄ»°Ìâ¡£
2. I would like to see more concrete raw data on the quantitati ...

ºÃµÎºÃµÎ£¡¸Ðл£¡ÎÒÒ»Ö±ÊÖ»úapp¿´²Å·¢ÏÖÄúµÄ»Ø¸´£¡ÎÒÔںúøÄÄØ
9Â¥2022-06-14 22:05:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

С¹û¶³123

½ð³æ (ÖøÃûдÊÖ)

10Â¥2022-06-28 09:57:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÏÂÓêÌì?? µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +14 Ò»ÑùYWY 2026-04-06 14/700 2026-04-08 23:00 by Öí»á·É
[¿¼ÑÐ] ÉúÎïѧ328·ÖÇóµ÷¼Á +9 ÉÁµçkkl 2026-04-08 10/500 2026-04-08 21:42 by liuhuiying09
[¿¼ÑÐ] ²ÄÁÏ¿¼ÑÐÇóµ÷¼Á×Ü·Ö280 +30 mkjlz1 2026-04-06 35/1750 2026-04-08 21:25 by cyh¡ª315
[¿¼ÑÐ] 327Çóµ÷¼Á +12 Xxjc1107. 2026-04-06 12/600 2026-04-08 16:46 by luoyongfeng
[¿¼ÑÐ] 280Çóµ÷¼Á +9 Àîrien 2026-04-04 9/450 2026-04-08 13:20 by lijunpoly
[¿¼ÑÐ] 315Çóµ÷¼Á +17 СÑòСÑò_ 2026-04-02 18/900 2026-04-07 22:01 by lijunpoly
[¿¼ÑÐ] 363Çóµ÷¼Á +9 zh096 2026-04-04 9/450 2026-04-07 21:51 by 418490947
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +12 ÏàÐűػá¹ââÍòÕ 2026-04-06 15/750 2026-04-07 21:22 by ÇÇßÕßÕßÕ
[¿¼ÑÐ] 318Çóµ÷¼Á +5 ÀîÇàɽɽɽ 2026-04-07 5/250 2026-04-07 18:24 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÉúÎ﹤³ÌÇóµ÷¼Á +13 ϲ»¶»¹ÊDz»¸ÊÐÄ 2026-04-05 13/650 2026-04-07 16:55 by Ecowxq666£¡
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ó¢¶þÊý¶þÇóµ÷¼Á +4 À¶¼ãƬ 2026-04-06 4/200 2026-04-07 12:30 by dongzh2009
[¿¼ÑÐ] һ־Ը̫ԭÀí¹¤´óѧ¼ÆËã»ú¼¼Êõר˶348£¬Çóµ÷¼ÁÖ¸µ¼ +3 nexious 2026-04-05 3/150 2026-04-07 08:19 by jp9609
[¿¼ÑÐ] 348Çóµ÷¼Á +6 wukira 2026-04-04 6/300 2026-04-05 18:11 by Öí»á·É
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +6 cs0106 2026-04-05 6/300 2026-04-05 16:34 by imissbao
[¿¼ÑÐ] 272Çóµ÷¼Á +4 µçÆøÀî 2026-04-05 4/200 2026-04-05 10:41 by lbsjt
[¿¼ÑÐ] 083200 333Çóµ÷¼Á +3 Ê®¶þ£¡£¡ 2026-04-04 3/150 2026-04-05 08:28 by barlinike
[¿¼ÑÐ] 322Çóµ÷¼Á +6 FZAC123 2026-04-03 6/300 2026-04-03 22:23 by ¿ÆÑÐСר¼Ò
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +5 ´Þwj 2026-04-03 5/250 2026-04-03 15:06 by arrow8852
[¿¼ÑÐ] 285Çóµ÷¼Á +8 AZMK 2026-04-02 11/550 2026-04-02 20:16 by yulian1987
[¿¼ÑÐ] Çóµ÷¼Á 302·Ö³õÊÔ 0854 +5 Áæ¿ÉÀÖ 2026-04-02 5/250 2026-04-02 17:53 by ±ÊÂä½õÖÝ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û